Walmart launches private brand insulin for diabetes patients
Walmart launched a private brand of insulin this week aimed at reducing costs for people with diabetes.
- Walmart's ReliOn brand will offer analog insulin vials for $72.88 and FlexPens for $85.88, according to a company news release.
Why it matters: Diabetes is an expensive and prevalent disease.
- People with diabetes incur about $9,600 a year on diabetes-related medical expenses, according to the American Association of Diabetes.
- 34.2 million people in the U.S., or 10% of the population, have diabetes, according to the CDC.
- In Arkansas, nearly 15% of the state's population has diabetes.
What they're saying: The new products will save customers 58% to 75%, according to Walmart. These numbers are based on costs before insurance.
Details: A prescription is required. The products will be available at Walmart pharmacies this week and at Sam's Club in mid-July.
More NW Arkansas stories
No stories could be found
Get a free daily digest of the most important news in your backyard with Axios NW Arkansas.